FDA approves rapid-acting inhaled insulin for children

The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes.

Low-cost mental health tool helps refugees in limbo

A simple self-help workbook paired with brief phone support can make a measurable difference to the mental health of displaced refugees, a new study has found. In Indonesia, where UNSW researchers tested the intervention, ...

How overlooked social connections can prevent suicide

Treatment of a serious mental illness that can lead to suicide, such as major depressive disorder, often centers on medication and talk therapy with little or no consideration of factors such as social isolation or financial ...

page 4 from 6